Bain Capital Life Sciences Opportunities IV GP, LLC — SEC Form 4 filings

SEC reporting owner CIK 2015657. 1 Form 4 filing on record with FilingPulse; latest filed 2025-01-13.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2025-01-13 to 2025-01-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Olema Pharmaceuticals, Inc. (OLMA)10% owner11 leg · 300,000 sh · $1,727,3702

Form 4 filings — Bain Capital Life Sciences Opportunities IV GP, LLC

FiledFormIssuerReported transactionsSource
2025-01-134Olema Pharmaceuticals, Inc. (OLMA)
jointly with Bain Capital Life Sciences Investors, LLC, Bain Capital Life Sciences IV General Partner, LLC, Bain Capital Life Sciences Fund IV, L.P., Bain Capital Life Sciences Opportunities IV, L.P.
Purchase (P): 300,000 @ $5.76 · Other (J): 3,500,000 · Other (J): 3,500,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2015657 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →